Stock LSL LSL PHARMA GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

End-of-day quote Toronto S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
0.5 CAD +2.04% Intraday chart for LSL Pharma Group Inc. -1.96% +3.09%
Jun. 05 LSL Pharma to Raise $4.5 Million Via Private Placements MT
Jun. 05 LSL Pharma Group Inc. announced that it expects to receive CAD 3 million in funding CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
GL
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
AQ
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
GL
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV
GL
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
GL
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
GL
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
AQ
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
GL
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
GL
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
AQ
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million
GL
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
GL
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
AQ
LSL Pharma Group Secures $6.44 Million as the First Closing of Concurrent Non-Brokered Private Placements
GL
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million
GL
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million
AQ
LSL Pharma Group Announces an Extension of its Convertible Debentures Offering
GL
LSL Pharma Group Announces an Extension of its Convertible Debentures Offering
AQ
LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering
GL
LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSL Stock
  4. News LSL Pharma Group Inc.
  5. Press Releases